role of progesterone receptor dysregulation in the

36
Decidua/ Fetal Membrane Frederick Schatz, PhD Umit A. Kayisli, PhD Ozlem Guzeloglu-Kayisli, PhD Nihan Semerci, MSc Kellie Larsen, BS Charly Lockwood, MD USF R esearch Team Role of Progesterone Receptor Dysregulation in the Pathogenesis of Preterm Birth: Why would Progesterone supplementation work? Theme 4

Upload: others

Post on 30-Nov-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Role of Progesterone Receptor Dysregulation in the

Theme 4

Decidua/ Fetal Membrane

Frederick Schatz, PhDUmit A. Kayisli, PhDOzlem Guzeloglu-Kayisli, PhDNihan Semerci, MScKellie Larsen, BSCharly Lockwood, MD

USF Research Team

Role of Progesterone Receptor Dysregulation in the

Pathogenesis of Preterm Birth: Why would

Progesterone supplementation work?

Theme 4

Page 2: Role of Progesterone Receptor Dysregulation in the

Theme 4

Does Progesterone (P4) prevent spontaneous PTB?Meis et al (N Engl J Med. 2003) randomized 459 women with prior spontaneous singleton PTB <37 weeks to weekly 250 mg 17-OHP (i.m.) vs. placebo from 16-20 weeks until 36 weeks and noted 17-OHP reduced risk of delivery :<37 weeks (36 vs 55%) [RR 0.66; 95% CI: 0.54-0.81]<32 weeks (11 vs 20%) [RR 0.58; 95% CI: 0.37-0.91]

Dodd et al conducted a meta-analysis (Cochrane Syst Rev. 2013) of RCT of P4 administration for prevention of recurrent PTB (11 trials, n = 1899 women) and noted P4 lowered risks for: Birth <34 weeks [RR 0.31, 95% CI: 0.14-0.69]Birth <37 weeks [RR 0.55, 95% CI: 0.42-0.74]Neonatal death [RR 0.45, 95% CI: 0.27-0.76)

Page 3: Role of Progesterone Receptor Dysregulation in the

Theme 4

Does P4 prevent spontaneous PTB?OPPTIMUM trial (Lancet. 2016) 1228 women at high risk (prior PTB ≤34 weeks, CL ≤25 mm, or positive fFN, plus clinical risk factors) randomized to vaginal P4 200 mg daily or placebo from 22-24 weeks to 34 weeks. Major findings were that P4 did not significantly reduce fetal death or PTB < 34 weeks or severe neonatal outcomes.

PROGRESS trial (Plos Med. 2017) randomized 787 women with prior PTB to vaginal P4 100 mg vs. placebo from 20-24 weeks to 34 weeks and observed nodifference in PTB rates, birth weights or prevalence of RDS or serious neonatal sequelae.

Page 4: Role of Progesterone Receptor Dysregulation in the

Central Role Played by Decidua in Mediating Parturition

AmnionChorion

fFNDeciduaBasalis Decidua Parietalis

Theme 4: Decidua

Physiological: Source of PG, IL-8, IL-6, and MMPs.

Pathological: Source of IL-1β and thrombin in infection and abruption associated PTB, respectively.

Page 5: Role of Progesterone Receptor Dysregulation in the

Cell Types at the Maternal-Fetal Interface

T : Trophoblast

NK : Natural Killer Cell

DC : Decidual Cell

M : Macrophage

L : T-lymphocyte

*** Of note that decidual cells are the major cell type ( >50%)

at the maternal-fetal interface

Theme 4: Decidua

Page 6: Role of Progesterone Receptor Dysregulation in the

PR Expression is restricted to Decidual Cells

at the Maternal-Fetal Interface

RED: Vimentin (identifies decidual cells)Gray: Cytokeratin (identifies Interstitial trophoblast)Brown: PR or GR (arrows for DCs; arrowheads for IT’s)

Theme 4: Decidua

Page 7: Role of Progesterone Receptor Dysregulation in the

PR Expression in Decidua Parietalis and BasalisTheme 4: Decidua

Brown: PR Red: Vimentin

DC: arrows IT: arrowheads

P<0.05P<0.05

Parietalis/Pre-Contract Basalis/Pre-Contract.

Parietalis/Contraction Basalis/Contraction

(Lockwood et al. JCEM 2010;95(5):2271-75)

Page 8: Role of Progesterone Receptor Dysregulation in the

SUMMARY-I

PR expression is restricted to decidual cells at the maternal-fetal interface. Decidual cell PR expression significantly

decreases in laboring vs. non-laboring specimens at term. GR expressed primarily by interstitial

trophoblast and its expression does not change in laboring vs. non-laboring specimens.

Theme 4: Decidua

Page 9: Role of Progesterone Receptor Dysregulation in the

Lockwood CJ et. al. JCEM 2010 May;95(5):2271-5

Theme 4: Decidua

Decidual-Chronic Inflammation and PTB

BV is associated with PTB (OR 1.95-2.19) and facilitates over-growth of mycoplasma sp., gardnerella, gram (-) bacteria, strep. and staph(Am J Ob Gyn 1995; 173:1231-5; NEJM 1995;333:1737-42; Ob/Gyn 1996;87:656-60).

Prevalence of a Lactobacillus-poor vaginal community state type (CST 4) inversely correlated with GAD (P = 0.0039). PTD Risk greater with CST 4 plus Gardnerella or Ureaplasma.

(Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11060-5. )

Page 10: Role of Progesterone Receptor Dysregulation in the

Lockwood CJ et. al. JCEM 2010 May;95(5):2271-5

Theme 4: Decidua

Bacterial products (endotoxins and exotoxins) bind to decidual and fetal membrane amnio-chorion TLR-4 and -2 to induce local IL-1β (AJOG 2003; 189:139-47; Infect Immun 2004; 72:5799-806; AJOG 2004;

191:1346-55; Immunology. 2002;107:145-51).

IL-1β enhances levels of NF-κB in decidua and fetal membranes to induce MMP-1,3, & 9, and COX-2 expression while inhibiting chorion PGDH (Mol Human Reprod 2001; 7:81-6).

Of 1025 women with spontaneous PTB < 34 weeks, chorioamnionitis/IUI was present in 38% (Am J Obstet Gynecol 2015; Feb. pii: S0002-9378(15)00132-5. E-pub).

Decidual-Chronic Inflammation and PTB

Page 11: Role of Progesterone Receptor Dysregulation in the

Decreased Nuclear PR Expression in DCs

at the Maternal-Fetal Interface of CAM-associated PTB

Vimentin: Red

PR: Brown

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

Page 12: Role of Progesterone Receptor Dysregulation in the

Cultured Human Primary Term Decidual Cells

Theme 4: Decidua

Page 13: Role of Progesterone Receptor Dysregulation in the

IL-1β Reduces PR mRNA and Protein Expression in Cultured Term DCs.

* p <0.05 vs. E2; # p <0.05 vs. E2ѱ p <0.05 vs. E2 + MPA

E2 E2+MPAE+IL1β EM+IL1β

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

Page 14: Role of Progesterone Receptor Dysregulation in the

IL-1β Induces COX-2, but not Cox-1 Expression in Cultured Term DCs

*p <0.05 vs. E2; #p <0.05 vs. E2 + MPA;ѱ p <0.05 vs. E2+IL-1β.

qRT-PCR Western Blot

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

Page 15: Role of Progesterone Receptor Dysregulation in the

PGE2 ELISA in CMS.

*p <0.05 vs. E2#p <0.05 vs. E2+ MPAѰp <0.05 vs. E2+IL-1β

PGF2α ELISA in CMS.

*p <0.05 vs. E2#p <0.05 vs. E2+ MPAѰp <0.05 vs. E2+IL-1β

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

IL-1β Induces Secretion of PGE2 and PGF2α

in Term DC Cultures

Page 16: Role of Progesterone Receptor Dysregulation in the

PGF2α but not PGE2 Reduces PR Expression

in Term DC Cultures

Immunoblot analysis of PR levels in term DCs treated with E2 + MPA or Org ±10-6 M PGE2 or PGF2α for 24 h.

Org: Org2058 (pure progestin)

Note that PGE2 did not change whereas PGF2α significantly reduced DC PR levels.

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

Page 17: Role of Progesterone Receptor Dysregulation in the

Inhibition of COX-2 does not Reverse IL-1β Suppressed

PR Expression in Term DC Cultures

Of note: Indomethacin alone has no effect on PR levels, while its combination with

IL-1β induces further decreases in PR levels.

Indo: Indomethacin, (10-6 M, non-selective COX inhibitor)

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

mRNA

Page 18: Role of Progesterone Receptor Dysregulation in the

IL-1β Activates

Multiple Signaling Cascades in Term DCs

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

Immunoblot analysis of following 15

min E2 +MPA ± IL-1β treatment of term

DCs for phospho (Ph-) and total (T-)

levels of:

1) p65 NF-ĸB,

2) ERK1/2 MPAK,

3) p38 MAPK,

4) AKT

Page 19: Role of Progesterone Receptor Dysregulation in the

Immunoblotting of term DCs treated

with: E2+MPA (EM) ± IL1β ± NF-ĸB

inhibitor III (NFIII) or ± ERK1/2 inhibitor

PD98059 (PD) or ± p38 MAPK inhibitor

SB203580 (SB) for PR-A and PR-B

expression.

Note that ERK1/2 inhibitor (PD)

significantly reverses IL-1β reduced PR

levels, whereas neither the NF-ĸB

inhibitor (NFĸB III) nor the p38 inhibitor

(SB) reversed this effect.

P<0.05

Theme 4: Decidua

Guzeloglu-Kayisli et al J Pathol. 2015;237(4):423-34.

Inhibition of ERK1/2 MAPK Reverses IL-1β ReducedDC expressed PR

Page 20: Role of Progesterone Receptor Dysregulation in the

Expression of Ph-ERK1/2 and T-ERK1/2 MAPK in DCs and ITs in GA-matched Control vs.

Abruption-Related Decidua

DCs : ArrowheadsITs : Arrows Lockwood CJ et al. Am J Pathol. 2012; 181: 2138–48

T-ER

K1/

2Ph

-ER

K1/

2

Normal Abruption

Page 21: Role of Progesterone Receptor Dysregulation in the

Theme 4: Decidua

SUMMARY-II

Decreased PR expression in CAM vs. GA-matched

control.

IL-1β inhibits PR mRNA and protein levels in

cultured decidual cells.

This inhibitory effect on PR expression is primarily

mediated by IL-1β activation of phospho-ERK1/2

signaling

Page 22: Role of Progesterone Receptor Dysregulation in the

Theme 4: Decidua

STRESS AND PTB

Combination of Depression and PTSD strongly linked to PTB (OR of 4.08; 95% CI: 1.27-13.15).

SSRI, both with (OR= 2.1; 95% CI: 1.0-4.6) and without (1.6; 1.0-2.5) MDD is associated with PTB

FKBP51 expression increased in frontal cortex of MDD patients and SNPs associated with FKBP51 over-expression linked to MDD/PTSD

(Yonkers K et al. JAMA Psychiatry. 2014; 71:897-904; Yonkers KA et al. Epidemiology. 2012; 23:677-

85; Tatro ET et al. J Neuroimmune Pharmacol. 2009; 4:218-26; Zheng D et al. JBC. 2016;

291:17897-906)

Page 23: Role of Progesterone Receptor Dysregulation in the

Steroid Receptor (PR, GR etc.)

FKBP-51/52 Interaction with the Steroid ReceptorsFKBP51 or FKBP52

Theme 4: Decidua

Page 24: Role of Progesterone Receptor Dysregulation in the

FKBP51 and 52

• FKBP51 and 52 differentially affect Steroid

Receptor functions.

• FKBP52 potentiates PR and GR activity.

• FKBP51 attenuates PR and GR responses.

• FKBP51 and 52 assemble with ER, but neither

co-chaperone affects ER activity.

Theme 4: Decidua

Page 25: Role of Progesterone Receptor Dysregulation in the

Expression of FKBP51 at the Maternal-Fetal Interface

Dec

idua

par

ieta

lisD

ecid

ua b

asal

is

Before Contraction After Contractions

Theme 4: Decidua

FKBP51: Brown Vimentin: Red Cytokeratin: Grey DC: Arrows ITs: Arrowheads

Schatz et al. Am J Pathol. 2015: 185 (9): 2402–2411

Page 26: Role of Progesterone Receptor Dysregulation in the

FKBP51 mRNA Levels in Term DC, Cytotrophoblast and Syncytiotrophoblast Cultures

FKBP51 mRNA expression

following 6 h of treatment with

dexamethasone (Dex).

TDC: Term decidual cells;

CTY: Cytotrophoblast;

SCT: Syncytiotrophoblast

Theme 4: Decidua

Schatz et al. Am J Pathol. 2015: 185 (9): 2402–2411

Page 27: Role of Progesterone Receptor Dysregulation in the

FKBP51 and FKBP52 mRNA Expression in Term DCs

FKBP51 and 52 mRNA expression

following 6 h of treatment of Decidual

cells with: E2; MPA, a mixed progestin-

glucocorticoid; Dex, a pure

glucocorticoid; and Org2058 (Org), a

pure progestin.

Theme 4: Decidua

Schatz et al. Am J Pathol. 2015: 185 (9): 2402–2411

Page 28: Role of Progesterone Receptor Dysregulation in the

FKBP51 reduces PR binding to DNA (PRE) by EMSA

Theme 4: Decidua

Schatz et al. Am J Pathol. 2015: 185 (9): 2402–2411

Page 29: Role of Progesterone Receptor Dysregulation in the

Theme 4: Decidua

FKBP51 WT♂ X FKBP51 KO♀

XFKBP51 WT♂ X FKBP51 WT♀

♂12-14 weeks old ♀ 6-8 weeks old

Restrain stress was applied 1h x 3 each day on days E8 to E18

Morning serum collected within 30 min of 1st stress treatment on E11

Between day E18-22, delivery controlled at each 4 h interval.

♂12-14 weeks old ♀ 6-8 weeks old

Mating x 4h Vaginal smear/sperm+ 0 d.c.

Role of FKBP51 in Stress-Induced PTB

using FKBP51-/- Mice

Page 30: Role of Progesterone Receptor Dysregulation in the

Mean ± SE: 20.25 ± 0.29 (N=11) vs. 19.10 ± 0.26 (N=10)

Prolong Gestation in Non-Stressed FKBP51-/- vs FKBP51+/+ Mice

Theme 4: Decidua

Plot 1

Non-Stress

17

18

19

20

21

Ges

tatio

nal L

engt

h

FKBP51+/+ FKBP51-/-

*

* p=0.01 KO NS vs WT NS

Page 31: Role of Progesterone Receptor Dysregulation in the

Theme 4: Decidua

Prenatal Stress induces PTB in WT Mice

Mean ± SEM; 18.72 ± 0.03 (N=10) vs. 19.10 ± 0.26 (N=10)

17.0

17.5

18.0

18.5

19.0

19.5

20.0G

esta

tiona

l Len

gth

Non-Stress Stress

* p=0.018 WT ST vs WT NS FKBP51+/+

*

Page 32: Role of Progesterone Receptor Dysregulation in the

Mean ± SE; 19.45 ± 0.21 (N=10) vs. 18.72± 0.03 (N=10)

Gestational Length is Significantly Longer in Stressed

induced FKBP51 KO vs. WT mice

Theme 4: Decidua

Plot 1

n=11n=11

Ges

tatio

nal L

engt

h

FKBP51+/+ FKBP51-/- Stress

*

* p=0.002 KO ST vs WT ST

17.0

17.5

18.0

18.5

19.0

19.5

20.0 *

Page 33: Role of Progesterone Receptor Dysregulation in the

Gestational Days

Bod

y W

eigt

h G

ain

(gr)

0

5

10

15

20

25

FKBP51+/+ NSFKBP51+/+ STFKBP51-/- NSFKBP51-/- ST

0 3 6 12 14 16 18

Similar Maternal Body Weight Gain and Food Intake

during Pregnancy in Stressed and Non-stressed Mice

Gestational Days

Food

Inta

ke (g

r)

150

175

200

225

250FKBP51+/+ NSFKBP51+/+ STFKBP51-/- NSFKBP51-/- ST

0 7 14 18

Theme 4: Decidua

Page 34: Role of Progesterone Receptor Dysregulation in the

SUMMARY - III

FKBP51 is mainly expressed by DCs vs ITs and that decidual FKBP51 expression increases in labor.

FKBP51 KO mice have longer gestational length and are more resistant to stress-induced PTB.

FKBP51 KO female mated with KO male mice are more resistant to stress-induced PTB compared to WT or KO females mated with WT male.

Theme 4: Decidua

Page 35: Role of Progesterone Receptor Dysregulation in the

IL-1β , TNF-α

Abruption Stress

PTB

Thrombin PAR

MMP-3

PR Activity

Membrane ruptureand

Cervical ripening

FKBP51

GR signaling

Chorioamnionitis

COX-2

PGF2α

Contractions

PR Levels

ERK1/2 MAPKERK1/2 MAPK

PGF2α

Page 36: Role of Progesterone Receptor Dysregulation in the

Theme 4

Decidua/ Fetal Membrane

Frederick Schatz, PhDUmit A. Kayisli, PhDOzlem Guzeloglu-Kayisli, PhDNihan Semerci, MScKellie Larsen, BSCharly Lockwood, MD

USF Research Team

Role of Progesterone Receptor Dysregulation in the

Pathogenesis of Preterm Birth: Why would

Progesterone supplementation work?

Theme 4